HIV-induced cysteine deficiency and T-cell dysfunction — a rationale for treatment with N-acetylcysteine
- 1 January 1992
- journal article
- review article
- Published by Elsevier in Immunology Today
- Vol. 13 (6) , 211-214
- https://doi.org/10.1016/0167-5699(92)90156-2
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- CD4 and CD8 T cells with high intracellular glutathione levels are selectively lost as the HIV infection progressesInternational Immunology, 1991
- Regulation of interleukin 2 production, interleukin 2 mRNA expression and intracellular glutathione levels in ex vivo derived T lymphocytes by lactateEuropean Journal of Immunology, 1991
- The Prognostic Value of Cellular and Serologic Markers in Infection with Human Immunodeficiency Virus Type 1New England Journal of Medicine, 1990
- Influence of the Extracellular Glutamate Concentration on the Intracellular Cyst(e)ine Concentration in Macrophages and on the Capacity to Release CysteineBiological Chemistry Hoppe-Seyler, 1989
- Low Concentrations of Acid-Soluble Thiol (Cysteine) in the Blood Plasma of HIV-1-Infected PatientsBiological Chemistry Hoppe-Seyler, 1989
- Immunopathogenic mechanisms of HIV infectionClinical Immunology and Immunopathology, 1989
- Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteineEuropean Journal of Clinical Pharmacology, 1988
- Soluble interleukin 2 receptors are elevated in patients with AIDS or at risk of developing AIDSClinical Immunology and Immunopathology, 1987
- Regulation of T-cell activation and T-cell growth factor (TCGF) production by hydrogen peroxideCellular Immunology, 1987
- Lung Protection by a Thiol-Containing Antioxidant: N-AcetylcysteineRespiration, 1986